Relmada Therapeutics, Inc. (RLMD)
NASDAQ: RLMD · Real-Time Price · USD
6.86
-0.24 (-3.38%)
Apr 2, 2026, 2:01 PM EDT - Market open
Relmada Therapeutics Market Cap
Relmada Therapeutics has a market cap or net worth of $719.55 million as of April 2, 2026. Its market cap has increased by 7,984.80% in one year.
Market Cap
719.55M
Enterprise Value
611.86M
1-Year Change
7,984.80%
Ranking
Category
Stock Price
$6.86
Market Cap Chart
Since September 30, 2015, Relmada Therapeutics's market cap has increased from $56.60M to $719.55M, an increase of 1,171.28%. That is a compound annual growth rate of 27.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2026 | 744.70M | 110.25% |
| Dec 31, 2025 | 354.20M | 2,156.05% |
| Dec 31, 2024 | 15.70M | -87.40% |
| Dec 29, 2023 | 124.60M | 18.67% |
| Dec 30, 2022 | 105.00M | -73.42% |
| Dec 31, 2021 | 395.00M | -24.17% |
| Dec 31, 2020 | 520.90M | 30.00% |
| Dec 31, 2019 | 400.70M | 1,125.38% |
| Dec 31, 2018 | 32.70M | 247.87% |
| Dec 29, 2017 | 9.40M | -28.24% |
| Dec 30, 2016 | 13.10M | -54.67% |
| Dec 31, 2015 | 28.90M | -48.94% |
| Sep 30, 2015 | 56.60M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MannKind | 782.58M |
| SELLAS Life Sciences Group | 756.04M |
| ORIC Pharmaceuticals | 750.18M |
| Alto Neuroscience | 747.84M |
| MeiraGTx Holdings | 740.35M |
| Maravai LifeSciences Holdings | 737.78M |
| Kura Oncology | 736.67M |
| Solid Biosciences | 726.13M |